Biomm Statistics
Total Valuation
Biomm has a market cap or net worth of BRL 982.52 million. The enterprise value is 1.04 billion.
| Market Cap | 982.52M |
| Enterprise Value | 1.04B |
Important Dates
The last earnings date was Friday, May 15, 2026.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Biomm has 136.84 million shares outstanding. The number of shares has increased by 9.70% in one year.
| Current Share Class | 136.84M |
| Shares Outstanding | 136.84M |
| Shares Change (YoY) | +9.70% |
| Shares Change (QoQ) | -4.33% |
| Owned by Insiders (%) | 12.66% |
| Owned by Institutions (%) | 90.51% |
| Float | 30.72M |
Valuation Ratios
The trailing PE ratio is 65.60.
| PE Ratio | 65.60 |
| Forward PE | n/a |
| PS Ratio | 3.05 |
| PB Ratio | 3.04 |
| P/TBV Ratio | 3.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 40.01, with an EV/FCF ratio of -9.48.
| EV / Earnings | 70.67 |
| EV / Sales | 3.23 |
| EV / EBITDA | 40.01 |
| EV / EBIT | 55.97 |
| EV / FCF | -9.48 |
Financial Position
The company has a current ratio of 1.77, with a Debt / Equity ratio of 0.28.
| Current Ratio | 1.77 |
| Quick Ratio | 0.69 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 3.45 |
| Debt / FCF | -0.82 |
| Interest Coverage | 1.79 |
Financial Efficiency
Return on equity (ROE) is 5.13% and return on invested capital (ROIC) is 4.16%.
| Return on Equity (ROE) | 5.13% |
| Return on Assets (ROA) | 2.28% |
| Return on Invested Capital (ROIC) | 4.16% |
| Return on Capital Employed (ROCE) | 4.75% |
| Weighted Average Cost of Capital (WACC) | 6.68% |
| Revenue Per Employee | 2.48M |
| Profits Per Employee | 113,385 |
| Employee Count | 130 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 1.70 |
Taxes
In the past 12 months, Biomm has paid 2.64 million in taxes.
| Income Tax | 2.64M |
| Effective Tax Rate | 15.20% |
Stock Price Statistics
The stock price has decreased by -30.76% in the last 52 weeks. The beta is 0.39, so Biomm's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | -30.76% |
| 50-Day Moving Average | 7.39 |
| 200-Day Moving Average | 7.53 |
| Relative Strength Index (RSI) | 49.10 |
| Average Volume (20 Days) | 258,410 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biomm had revenue of BRL 322.16 million and earned 14.74 million in profits. Earnings per share was 0.11.
| Revenue | 322.16M |
| Gross Profit | 111.51M |
| Operating Income | 18.61M |
| Pretax Income | 17.38M |
| Net Income | 14.74M |
| EBITDA | 25.62M |
| EBIT | 18.61M |
| Earnings Per Share (EPS) | 0.11 |
Balance Sheet
The company has 30.82 million in cash and 89.90 million in debt, with a net cash position of -59.08 million or -0.43 per share.
| Cash & Cash Equivalents | 30.82M |
| Total Debt | 89.90M |
| Net Cash | -59.08M |
| Net Cash Per Share | -0.43 |
| Equity (Book Value) | 323.36M |
| Book Value Per Share | 2.34 |
| Working Capital | 139.76M |
Cash Flow
In the last 12 months, operating cash flow was -85.31 million and capital expenditures -24.54 million, giving a free cash flow of -109.85 million.
| Operating Cash Flow | -85.31M |
| Capital Expenditures | -24.54M |
| Depreciation & Amortization | 7.01M |
| Net Borrowing | -25.22M |
| Free Cash Flow | -109.85M |
| FCF Per Share | -0.80 |
Margins
Gross margin is 34.61%, with operating and profit margins of 5.78% and 4.58%.
| Gross Margin | 34.61% |
| Operating Margin | 5.78% |
| Pretax Margin | 5.40% |
| Profit Margin | 4.58% |
| EBITDA Margin | 7.95% |
| EBIT Margin | 5.78% |
| FCF Margin | n/a |
Dividends & Yields
Biomm does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.70% |
| Shareholder Yield | -9.70% |
| Earnings Yield | 1.50% |
| FCF Yield | -11.18% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |